Potential for therapy with AML-derived dendritic cells.
Claxton
D
D
The University of Texas MD Anderson Cancer Center, Houston, USA.
Choudhury
A
A
D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*